National Resilience

National Resilience is a biotech company in BLUE ASH, United States, founded in 2020. It has raised $2.2B across 4 rounds, most recently a $250.0M Venture Round in June 2025.

Biomanufacturing CDMO | Biologics | Cell and Gene Therapy CDMO

Headquarters
BLUE ASH, Ohio
Employees
1001–5000
Founded
2020
Business Model
B2B
Total Funding
$2.2B
Last Round
$250.0M Venture RoundJun 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

National Resilience, Inc. (doing business as Resilience) is a North American contract development and manufacturing organization (CDMO) founded in 2020 and headquartered in Blue Ash, Ohio (previously based in San Diego, California). Launched with $800 million in venture funding, Resilience was built to broaden access to complex medicines and protect biopharmaceutical supply chains against disruption. The company specializes in end-to-end biomanufacturing for biologics, cell therapy, and gene therapy, offering named platform solutions including Sprout Solutions, Auto-T, DAR-T, Idea to Clinic, and Build Your Resilience. Resilience operates facilities across North America — in Blue Ash (HQ), Cincinnati, Philadelphia, and Toronto — and employs approximately 1,375–1,680 staff. In June 2025, the company announced a strategic wind-down of six underutilized manufacturing sites and secured up to $825 million in long-term financing to accelerate its focused CDMO strategy.

Summary

It lists 1001–5000 employees. It has raised $2.2B in total across 4 rounds, most recently a $250.0M Venture Round in Jun 2025. Investors include ARCH Venture Partners, 8VC and Oak Hill Capital Partners.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundJun 2025
$250.0M

Sign up to see all 5 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

National Resilience on Indexed.vc
<a href="https://indexed.vc/companies/national-resilience"><img src="https://indexed.vc/api/badge/company/national-resilience" alt="National Resilience on Indexed.vc" width="260" height="76" /></a>